Asparagus P-R Cannot Compete with First-line Diuretics in Lowering the Blood Pressure in Treatment-requiring Antihypertensives

[摘要]：A six week clinical surveillance of 163 patients receiving maximally tolerable doses of Asparagus P (R), a proprietary mixture pulversied dried asparagus root and parsley leaf, has not indicated any clinically useful antihypertensive effect. The profile of adverse events (with 7 patients leaving the surveillance early because of renally related complaints) contraindicates its use in hypertension or to promote flushing of the efferent tract in rental inflammatory conditions or urolithiasis. Copyright (c) 2009 John Wiley & Sons, Ltd.

[全文传递流程]：

一般上传文献全文的时限在1个工作日内